Our regulatory trackers provide current and accurate information about regulations that are in place around the world. They are presented in user-friendly maps and tables. These trackers are updated on a regular basis, providing data on current regulations in individual countries around the world, as well as proposed and enacted regulations in individual US states.
Welcome to the CBD-Intel US enacted law regulatory tracker, updated each month. Within this interactive map gain insight into the enacted bills for 22 US states, with more state coverage coming very...
Welcome to the new and improved CBD-Intel US state law regulatory tracker, updated every month and exclusively focused on state law. This interactive map allows you to search for states, zoom in and out from the map, view...
CBD-Intel's newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.
Use the tabs at the top of the map to select a specific regulatory field and click on an individual country...
Use our newly updated directory of stakeholders in the global CBD sector to find the most relevant organisations in key markets, with full Web, email, phone and address details. Available exclusively to CBD-Intel subscribers, this once-yearly updated database...
Sign up to our newsletter
Subscribe for the latest industry updates
Signup for our newsletter and keep an eye on the latest news!
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.